FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Optimer Pharma NDA for New Antibiotic

[ Price : $8.95]

Optimer Pharmaceuticals files an NDA for fidaxomicin, indicated for treating patients with clostridium difficile infection.

Onus is on Firms, FDA for Credible Social Media Info: Report

[ Price : $8.95]

A New England Journal of Medicine report says FDA and industry each should be responsible for the credibility of drug and device i...

FDA Expands Program on Medical Product Safety

[ Price : $8.95]

Federal Register Notice: FDA plans to expand its Conference Cooperative Agreement Program, awarded to the Brookings Institution to...

JAMA Study on OTC Labeling Finds Inconsistencies

[ Price : $8.95]

A new study reported online in the Journal of the American Medical Association finds high levels of variability and inconsistency ...

FDA Amends Regs to Include Tobacco

[ Price : $8.95]

Federal Register Direct final rule: FDA amends it s regulations to include tobacco products where appropriate.

Comment Sought on National Stockpile Regulations

[ Price : $8.95]

Federal Register Notice: FDA seeks comments on information collection requirements on labeling requirements for products held by t...

Comments Sought on FDA Focus Group Info

[ Price : $8.95]

Federal Register Notice: FDA seeks comments on FDA focus groups used to gauge public opinion on FDA-regulated products.

Comments Sought on Radioactive Drug Regs Info

[ Price : $8.95]

Federal Register Notice: FDA seeks comments on the information collection in regulations on the use of radioactive drugs for basic...

Latest FDA Warning Letters

[ Price : $8.95]

In its latest batch of Warning Letters, FDA cites Align Technology, Anchor Products Co., Energy Technology, and Gunnell.

Inspire Medical to Begin Pivotal Apnea Trial

[ Price : $8.95]

FDA gives Inspire Medical Systems approval to begin a pivotal clinical trial called STAR (Stimulation Therapy for Apnea Reduction)...